Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling

Por Khamrang, Themmila, Hung, Kuo-Chen, Hsia, Chih-Hsuan, Hsieh, Cheng-Ying, Velusamy, Marappan, Jayakumar, Thanasekaran, Sheu, Joen-Rong
Publicado no Int J Mol Sci (2017)

Possible Molecular Targets of Novel Ruthenium Complexes in Antiplatelet Therapy

Por Jayakumar, Thanasekaran, Hsu, Chia-Yuan, Khamrang, Themmila, Hsia, Chih-Hsuan, Hsia, Chih-Wei, Manubolu, Manjunath, Sheu, Joen-Rong
Publicado no Int J Mol Sci (2018)

A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies

Por Hsia, Chih-Hsuan, Velusamy, Marappan, Sheu, Joen-Rong, Khamrang, Themmila, Jayakumar, Thanasekaran, Lu, Wan-Jung, Lin, Kuan-Hung, Chang, Chao-Chien
Publicado no Sci Rep (2017)

Ir-6: A Novel Iridium (III) Organometallic Derivative for Inhibition of Human Platelet Activation

Por Shyu, Ren-Shi, Khamrang, Themmila, Sheu, Joen-Rong, Hsia, Chih-Wei, Velusamy, Marappan, Hsia, Chih-Hsuan, Chou, Duen-Suey, Chang, Chao-Chien
Publicado no Bioinorg Chem Appl (2018)

Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets

Por Hsia, Chih-Hsuan, Jayakumar, Thanasekaran, Sheu, Joen-Rong, Tsao, Shin-Yi, Velusamy, Marappan, Hsia, Chih-Wei, Chou, Duen-Suey, Chang, Chao-Chien, Chung, Chi-Li, Khamrang, Themmila, Lin, Kao-Chang
Publicado no Molecules (2018)